Hematologic Malignancies CME: 2021

The care of patients with hematologic malignancies is evolving rapidly. These video highlights discuss new developments in the diagnosis and treatment of hematologic malignancies presented at the 2021 Annual Meeting of the American Society of Hematology (ASH).

During this one-day virtual course, faculty shared the latest updates in lymphoma, leukemia, myeloma, and stem cell transplantation. Through case-based presentations and Q&A, users gained a deeper understanding of emerging treatments available for blood cancers and blood disorders and learned how these new therapies could be integrated into daily practice.


Advances in Allogenic Transplantation

Mahasweta Gooptu, MD

Mahasweta Gooptu, MD

Physician Assistant
Professor of Medicine, Harvard Medical School

Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia and the Myeloproliferative Neoplasms

Daniel DeAngelo, MD, PhD

Daniel DeAngelo, MD, PhD

Chief, Division of Leukemia
Institute Physician
Professor of Medicine, Harvard Medical School

Chronic Lymphocytic Leukemia Updates

Inhye Ahn, MD

Inhye Ahn, MD

Physician
Member of the Faculty of Medicine, Harvard Medical School

Myelodysplastic Syndromes and Acute Myeloid Leukemia

Richard Stone, MD

Richard Stone, MD

Chief of Staff
Director, Translational Research, Adult Leukemia Program
Institute Physician
Professor of Medicine, Harvard Medical School

Multiple Myeloma

Omar Nadeem, MD

Omar Nadeem, MD

Clinical Director, Myeloma Cellular Therapies Program
Physician
Instructor in Medicine, Harvard Medical School

Hemostasis and Hemoglobinopathies

Maureen Achebe, MD, MPH

Maureen Achebe, MD, MPH

Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women's Hospital Outpatient Infusion Center
Director, Brigham and Women's Hospital Sickle Cell Program

Lymphoma ASH Highlights 2021

Jennifer Crombie, MD

Jennifer Crombie, MD

Physician
Instructor in Medicine, Harvard Medical School